Sarosiek, S., Kwok, M., Kapoor, P., Chory, H., Budano, N., Nguyen, J., Eurell, A., Meid, K., Guijosa, A., Tsakmaklis, N., Hunter, Z., Branagan, A., Treon, S., Castillo, J. (2025). Deep responses following treatment with loncastuximab tesirine (WM-NET1 trial) in patients with Relapsed/Refractory including those withhigh-risk, TP53-altered Waldenström macroglobulinemia.. Blood. https://doi.org/10.1182/blood-2025-581